CARLSBAD, Calif.–(BUSINESS WIRE)—- $LCTX #LineageCellTherapeutics–Q4 & FYE 2022 Earnings
Author: Business Wire
LENSAR to Report Fourth Quarter and Full Year 2022 Financial Results on Thursday, March 16, 2023
ORLANDO, Fla.–(BUSINESS WIRE)–LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of cataracts, today announced that the Company’s fou…
GenSight Biologics Announces Publication of LUMEVOQ® Safety Data over 5-Year Period in renowned Peer-Reviewed American Journal of Ophthalmology
PARIS–(BUSINESS WIRE)–Regulatory News: GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative diseases and cent…
Virscio Announces Launch of Pathology and Tissue Pharmacodynamics Services Division
NEW HAVEN, Conn. & CHRIST CHURCH, ST. KITTS & NEVIS, West Indies–(BUSINESS WIRE)–Virscio accelerates investment in advanced histology capabilities to complement in vivo translational R&D service strengths
GoCheck Kids Names Naveen Kathuria as Chief Executive Officer
NASHVILLE, Tenn.–(BUSINESS WIRE)–GoCheck Kids, the leading digital vision screening platform for children, has named Naveen Kathuria as its new Chief Executive Officer. Kathuria brings deep experience leading healthcare organizations that serve vulne…
National Vision Names 2022-2023 Scholarship Program Winners, Giving $12,500 to Next Generation of ODs
DULUTH, Ga.–(BUSINESS WIRE)–National Vision, Inc., the nation’s second largest optical retailer providing quality, affordable eye care and eyewear, announced the winners of its eighth annual scholarship program today, which recognizes the best and br…
Diabetic Retinopathy Pipeline Research Report 2022: Featuring Insights on 60+ Companies and Drugs in the Sector – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Diabetic Retinopathy – Pipeline Insight, 2022” clinical trials has been added to ResearchAndMarkets.com’s offering. This “Diabetic Retinopathy – Pipeline Insight, 2022” report provides comprehensive insights about 60+ comp…
Orthokeratology Lenses Global Market Report 2022: Featuring Alpha, Bausch & Lomb, Essilor, E&E Optics, Procornea & More – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Orthokeratology Lenses Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 To 2030” report has been added to ResearchAndMarkets.com’s of…
Veero® Launches EyeSize, A Software Solution That Uses Advanced AI and Computer-Vision Technology to Achieve Precise Virtual Eyewear Fitting
BOSTON–(BUSINESS WIRE)–AI-software innovator Veero® today introduced Veero® EyeSize, a virtual-fit solution for eyewear retailers that uses a combination of proprietary AI and computer-vision technology to deliver precise frame fitting, reduce return…
NovaBay Pharmaceuticals Launches Avenova® Eye Health Support, a New Antioxidant-Rich Oral Supplement to Comfort Dry Eyes and Promote Overall Eye Health
EMERYVILLE, Calif.–(BUSINESS WIRE)–NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) announces the launch of OTC Avenova Eye Health Support oral supplement featuring a combination of MaquiBright®, a nutrient-rich, antioxidant-dense extract of the s…
Jimmy Palacios Joins Sonrava Health as Chief Digital Officer
DALLAS–(BUSINESS WIRE)–Jimmy Palacios has joined Sonrava Health as Chief Digital Officer, effective March 6. Sonrava Health is a national family of health and wellness companies – including differentiated dental office brands, dental and vision benef…
Harrow Announces Appointment of Mark Mannebach, Ph.D., R.Ph. as Head of Regulatory Affairs and Pharmacovigilance
NASHVILLE, Tenn.–(BUSINESS WIRE)—- $HROW–Harrow (Nasdaq: HROW), a leading U.S. eyecare pharmaceutical company, today announced the appointment of Mark Mannebach, Ph.D., R.Ph. as Head of Regulatory Affairs and Pharmacovigilance, responsible for over…
RG6501 (OpRegen®) Phase 1/2a Results to Be Featured at 2023 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting in Presentation by Eyal Banin, M.D., Ph.D.
CARLSBAD, Calif.–(BUSINESS WIRE)—- $LCTX #LineageCellTherapeutics–Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today announced t…
EyeBio Announces First Asset in Innovative Pipeline of Retinal Disease Treatments and Appoints Industry Leaders to Executive Team
LONDON & NEW YORK–(BUSINESS WIRE)–Eyebiotech Limited (EyeBio), a privately held ophthalmology biotechnology company dedicated to developing and delivering a new generation of therapies to patients with sight-threatening eye diseases, today announced …
National Vision Holdings, Inc. Announces Participation in the UBS Global Consumer and Retail Conference
DULUTH, Ga.–(BUSINESS WIRE)–National Vision Holdings, Inc. (NASDAQ: EYE) today announced the Company is scheduled to participate in a fireside chat at the UBS Global Consumer and Retail Conference on Wednesday, March 15, 2023, at 11:00 a.m. Eastern T…
Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PARSIPPANY, N.J.–(BUSINESS WIRE)–Iveric Bio granted equity-based awards pursuant to the Company’s 2019 Inducement Stock Incentive Plan to nine newly-hired, non-executive employees.
Visus Therapeutics to Attend TD Cowen’s 43rd Annual Health Care Conference
SEATTLE–(BUSINESS WIRE)– #VisusTx–Visus Therapeutics to Attend TD Cowen’s Health Care Conference. Topline Phase 3 data for best-in-class presbyopia candidate anticipated in 1H 2023.
Harrow to Announce Fourth Quarter 2022 Financial Results on March 23, 2023
NASHVILLE, Tenn.–(BUSINESS WIRE)—- $HROW–Harrow (Nasdaq: HROW), a leading U.S. eyecare pharmaceutical company, today announced that it will release its financial results for the fourth quarter and year ended December 31, 2022, on Thursday, March 23…
Bay Area Retina Associates (BARA) Offers the First-Ever FDA-Approved Treatment for Geographic Atrophy (GA), the Advanced Dry Form of Age-Related Macular Degeneration (AMD)
WALNUT CREEK, Calif.–(BUSINESS WIRE)–Geography Atrophy Treatment
S-Alpha Therapeutics, Inc. To Present at Ophthalmology Innovation Summit During 2023 OIS@SECO in Atlanta, GA, USA
SAN FRANCISCO–(BUSINESS WIRE)–S-Alpha Therapeutics, Inc., a company developing new solutions for children with Myopia, announced today that Youngmin Huh, Ph.D., Data Science Leader, will present interim data from clinical trial using its novel, inves…